Duality Advisers, LP Emergent Bio Solutions Inc. Transaction History

Duality Advisers, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$11.0 - $21.45 $225,434 - $439,596	20,494 Added 36.08%	77,298 $912,000
Q3 2022 Nov 03, 2022	SELL	$20.09 - $35.8 $177,716 - $316,686	-8,846 Reduced 13.47%	56,804 $1.19 Million
Q2 2022 Aug 08, 2022	BUY	$27.42 - $43.63 $1.62 Million - $2.57 Million	59,009 Added 888.56%	65,650 $2.04 Million
Q1 2022 May 09, 2022	SELL	$36.48 - $52.22 $502,621 - $719,487	-13,778 Reduced 67.48%	6,641 $273,000
Q4 2021 Feb 02, 2022	SELL	$33.11 - $55.01 $1.44 Million - $2.39 Million	-43,506 Reduced 68.06%	20,419 $888,000
Q3 2021 Nov 08, 2021	BUY	$50.07 - $66.05 $1.47 Million - $1.94 Million	29,401 Added 85.16%	63,925 $3.2 Million
Q2 2021 Aug 09, 2021	BUY	$56.61 - $80.46 $1.4 Million - $1.99 Million	24,730 Added 252.5%	34,524 $2.18 Million
Q1 2021 May 13, 2021	SELL	$86.23 - $125.19 $807,543 - $1.17 Million	-9,365 Reduced 48.88%	9,794 $910,000
Q4 2020 Feb 09, 2021	BUY	$79.17 - $111.47 $716,409 - $1.01 Million	9,049 Added 89.51%	19,159 $1.72 Million
Q3 2020 Nov 12, 2020	BUY	$81.91 - $134.94 $828,110 - $1.36 Million	10,110 New	10,110 $1.05 Million

159

33.7M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $473M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.